Clinical Trial Update: A Safety and Tolerability Study of AG-519 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of AG-519 in healthy subjects; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• AG-519 (AG-519)

Snippet

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Anemia | Phase 1 | Status: TERMINATED